Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
Placenta ; 147: 52-58, 2024 Mar 06.
Article in English | MEDLINE | ID: mdl-38316084

ABSTRACT

INTRODUCTION: Preeclampsia is a common hypertensive disorder of pregnancy. Several studies have demonstrated that protein aggregates, detected through urine congophilia, is associated with preeclampsia; however, it has yet to be investigated whether urine congophilia remains postpartum in these women. In this study, we aimed to augment prior studies and determine whether urine congophilia is present postpartum. METHODS: Women were recruited from Lyell McEwin Hospital, South Australia. Urine samples were collected during pregnancy and 6-months postpartum from women with non-preeclampsia pregnancies (n = 48) and women with pregnancies complicated by preeclampsia (n = 42). A Congo Red Dot blot test, total protein and creatinine levels from urine, as well as serum Soluble fms-like tyrosine kinase 1 to placental growth factor ratio (sFlt-1:PlGF), were assessed and correlated. RESULTS: Preeclamptic women exhibited increased urine congophilia (P < 0.01), sFlt-1:PlGF ratio (P < 0.0001) and total protein (P < 0.01) during pregnancy; with a positive correlation between urine congophilia and total protein across the entire cohort (P < 0.0001). Although urine congophilia was no longer detected 6-months postpartum in preeclamptic women, total protein remained elevated (P < 0.05). sFlt-1:PlGF ratio during pregnancy was positively correlated with congophilia across the cohort (P = 0.0007). Serum creatinine was also higher in preeclamptic women during pregnancy (P < 0.001). DISCUSSION: These results support that urine congophilia is significantly elevated in pregnancies complicated with preeclampsia and show that it does not continue postpartum, although larger cohort studies are needed to determine its feasibility as a diagnostic marker.


Subject(s)
Hypertension , Pre-Eclampsia , Pregnancy , Female , Humans , Pre-Eclampsia/metabolism , Placenta Growth Factor , Postpartum Period , Cohort Studies , Vascular Endothelial Growth Factor Receptor-1/metabolism , Biomarkers
2.
Epigenetics Chromatin ; 16(1): 37, 2023 10 04.
Article in English | MEDLINE | ID: mdl-37794499

ABSTRACT

BACKGROUND: Genome-wide DNA methylation (DNAme) profiling of the placenta with Illumina Infinium Methylation bead arrays is often used to explore the connections between in utero exposures, placental pathology, and fetal development. However, many technical and biological factors can lead to signals of DNAme variation between samples and between cohorts, and understanding and accounting for these factors is essential to ensure meaningful and replicable data analysis. Recently, "epiphenotyping" approaches have been developed whereby DNAme data can be used to impute information about phenotypic variables such as gestational age, sex, cell composition, and ancestry. These epiphenotypes offer avenues to compare phenotypic data across cohorts, and to understand how phenotypic variables relate to DNAme variability. However, the relationships between placental epiphenotyping variables and other technical and biological variables, and their application to downstream epigenome analyses, have not been well studied. RESULTS: Using DNAme data from 204 placentas across three cohorts, we applied the PlaNET R package to estimate epiphenotypes gestational age, ancestry, and cell composition in these samples. PlaNET ancestry estimates were highly correlated with independent polymorphic ancestry-informative markers, and epigenetic gestational age, on average, was estimated within 4 days of reported gestational age, underscoring the accuracy of these tools. Cell composition estimates varied both within and between cohorts, as well as over very long placental processing times. Interestingly, the ratio of cytotrophoblast to syncytiotrophoblast proportion decreased with increasing gestational age, and differed slightly by both maternal ethnicity (lower in white vs. non-white) and genetic ancestry (lower in higher probability European ancestry). The cohort of origin and cytotrophoblast proportion were the largest drivers of DNAme variation in this dataset, based on their associations with the first principal component. CONCLUSIONS: This work confirms that cohort, array (technical) batch, cell type proportion, self-reported ethnicity, genetic ancestry, and biological sex are important variables to consider in any analyses of Illumina DNAme data. We further demonstrate the specific utility of epiphenotyping tools developed for use with placental DNAme data, and show that these variables (i) provide an independent check of clinically obtained data and (ii) provide a robust approach to compare variables across different datasets. Finally, we present a general framework for the processing and analysis of placental DNAme data, integrating the epiphenotype variables discussed here.


Subject(s)
DNA Methylation , Placenta , Humans , Pregnancy , Female , Infant, Newborn , Placenta/metabolism , Epigenesis, Genetic , Gestational Age , Genome
3.
J Asthma ; 60(10): 1907-1917, 2023 10.
Article in English | MEDLINE | ID: mdl-37021838

ABSTRACT

OBJECTIVE: Asthma occurs in ∼17% of Australian pregnancies and is associated with adverse perinatal outcomes, which worsen with poor asthma control. Consequently, the South Australian 'Asthma in Pregnancy' perinatal guidelines were revised in 2012 to address management according to severity. This study investigated if these revised guidelines reduced the impact of maternal asthma on risks of adverse perinatal outcomes before (Epoch 1, 2006-2011) and after the revision (Epoch 2, 2013-2018). METHODS: Routinely collected perinatal and neonatal datasets from the Women's and Children's Hospital (Adelaide, Australia) were linked. Maternal asthma (prevalence:7.5%) was defined as asthma medication use or symptoms described to midwives. In imputation (n = 59131) and complete case datasets (n = 49594), analyses were conducted by inverse proportional weighting and multivariate logistic regression, accounting for confounders. RESULTS: Overall, maternal asthma was associated with increased risks of any antenatal corticosteroid treatment for threatened preterm birth (aOR 1.319, 95% CI 1.078-1.614), any Cesarean section (aOR 1.196, 95% CI 1.059-1.351), Cesarean section without labor (aOR 1.241, 95% CI 1.067-1.444), intrauterine growth restriction (IUGR, aOR 1.285, 95% CI 1.026-1.61), and small for gestational age (aOR 1.324, 95% CI 1.136-1.542). After guideline revision, asthma-associated risks of any Cesarean section (p < 0.001), any antenatal corticosteroids (p = 0.041), and small for gestational age (p = 0.050), but not IUGR and Cesarean section without labor, were reduced. CONCLUSIONS: Clinical practice guidelines based on the latest evidence do not guarantee clinical efficacy. Since adverse perinatal outcomes did not all improve, this work highlights the need to evaluate the ongoing impact of guidelines on clinical outcomes.


Subject(s)
Asthma , Pregnancy Complications , Premature Birth , Child , Pregnancy , Female , Infant, Newborn , Humans , Pregnancy Outcome/epidemiology , Pregnancy Complications/drug therapy , Pregnancy Complications/epidemiology , Cesarean Section , Retrospective Studies , Premature Birth/epidemiology , Asthma/drug therapy , Asthma/epidemiology , Asthma/complications , Australia
4.
Reprod Sci ; 28(5): 1390-1402, 2021 05.
Article in English | MEDLINE | ID: mdl-33409870

ABSTRACT

Maternal alcohol consumption during pregnancy results in elevated vulnerability to intrauterine growth restriction, preterm birth, miscarriage, and stillbirth. Many of the detrimental effects of fetal alcohol exposure may be mediated through placental dysfunction; however, the exact mechanisms remain unknown. Here, we aimed to determine the effect of maternal alcohol exposure prior to and during early pregnancy on placental glucocorticoid receptor (GR) isoforms, associated GR regulated genes, and infant outcomes. Participants carrying singleton fetuses (n = 113) were recruited during early pregnancy. Amount and type of alcohol consumed over the last 12 months were obtained at 18 weeks of gestation. The level of drinking was separated into none (0 g/day), low (< 10 g/day), moderate (10-100 g/day), and heavy (> 100 g/day). At delivery, placental weight, infant sex, birthweight, and head circumference were recorded. Placental GR isoforms and genes involved in downstream signalling pathways were quantified. The majority of women (70.8%) consumed alcohol. Of these, most consumed low (48.8%) or moderate (37.5%) amounts. Placental weight was unaffected by alcohol consumption, but infants born to heavy drinkers tended to be lighter at birth. In female, but not male, placentae, maternal alcohol consumption resulted in increased GRαC and decreased GRαD1 cytoplasmic expression. In both female and male placentae, a dampened inflammatory response was evident with maternal alcohol consumption, involving downregulated IL6R and upregulated POU2F2 gene expression, respectively. Maternal alcohol consumption in the months prior to, and/or during early, pregnancy alters placental GR isoform and expression of some inflammatory genes in a sex-specific manner.


Subject(s)
Alcohol Drinking , Placenta/metabolism , Receptors, Glucocorticoid/metabolism , Adult , Birth Weight , Female , Gene Expression , Humans , Male , Pregnancy , Protein Isoforms/metabolism , Young Adult
5.
Placenta ; 84: 63-68, 2019 09 01.
Article in English | MEDLINE | ID: mdl-30975436

ABSTRACT

The role of steroids throughout pregnancy and their effect on placental physiology is well established, especially for estrogens, progestogens, and glucocorticoids; however, the role of androgens - particularly within the context of placental physiology - remains largely unexplored. Androgens are often defined as the male sex-steroids and are fundamental for the defeminisation and masculinisation of male fetuses. Therefore, the placenta may adapt to these steroids in a sex-specific manner, with males being more receptive to changes in these steroids concentrations, when compared with females; however, their involvement in female intrauterine development has been investigated in several studies and may suggest females have a level of responsiveness to these steroids. While the former may be true, studies have reported sex-specific differences in the expression and activity of factors involved in androgen biosynthesis and bioavailability, with males consistently demonstrating greater degrees of altered protein and gene expression when compared with females. Understanding the placental androgen axis is essential as many pregnancy comorbidities are associated with elevated concentrations of androgens and perturbed intrauterine development or growth. Indeed, it appears that specific pathophysiologies of pregnancy can modulate the activity of key factors involved in the placental androgen axis and this may contribute to the etiology of sex-specific developmental outcomes from certain pregnancy complications. This review will provide insight into what is currently known regarding androgen signalling and the human placenta, and how this complex system may regulate sex-specific growth and developmental outcomes in normal and adverse pregnancies.


Subject(s)
Androgens/physiology , Fetal Development , Placenta/metabolism , Placentation , Polymorphism, Single Nucleotide , Receptors, Androgen/genetics , Androgens/pharmacology , Estrogens/pharmacology , Female , Fetal Development/drug effects , Fetal Development/genetics , Glucocorticoids/pharmacology , Humans , Male , Placenta/drug effects , Placentation/drug effects , Placentation/genetics , Pregnancy , Progestins/pharmacology , Receptors, Androgen/metabolism , Sex Characteristics
6.
Obes Rev ; 19(9): 1248-1255, 2018 09.
Article in English | MEDLINE | ID: mdl-30035359

ABSTRACT

INTRODUCTION: Uncontrolled family factors may bias the estimation of the association between maternal smoking during pregnancy and offspring body mass index (BMI). The objective was to assess if there is an association between maternal smoking during pregnancy and offspring BMI z-score independent of factors in the siblings' shared environment and if such association is linear. METHODS: We performed an individual patient data meta-analysis using five studies providing sibling data (45,299 children from 14,231 families). In a multi-level model, separating within-family and between-family effects and with random intercept for families, we analysed the dose-response association between maternal number of cigarettes per day during pregnancy and offspring's BMI z-score using B-splines to allow for non-linear associations. RESULTS: A linear within-family effect for number of cigarettes smoked in the range from 1 to 30 cigarettes per day on the offspring's BMI z-score was observed. Each additional cigarette per day between sibling pregnancies resulted in an increase in BMI z-score of 0.007 (95% CI [0.006, 0.009]). A between family-effect emerged only with doses ≥25 cigarettes per day. CONCLUSIONS: The number of cigarettes mothers smoke per day during pregnancy is positively associated with offspring BMI z-score even among siblings, suggesting that the association is not entirely explained by confounding by family factors.


Subject(s)
Body Mass Index , Prenatal Exposure Delayed Effects/physiopathology , Smoking , Female , Humans , Pregnancy
7.
J Reprod Immunol ; 123: 88-93, 2017 09.
Article in English | MEDLINE | ID: mdl-28760578

ABSTRACT

Allergy is a chronic disease that can develop as early as infancy, suggesting that early life factors are important in its aetiology. Variable associations between size at birth, a crude marker of the fetal environment, and allergy have been reported in humans and require comprehensive review. Associations between birth weight and allergy are however confounded in humans, and we and others have therefore begun exploring the effects of early life events on allergy in experimental models. In particular, we are using ovine models to investigate whether and how a restricted environment before birth protects against allergy, whether methyl donor availability contributes to allergic protection in IUGR, and why maternal asthma during pregnancy is associated with increased risks of allergic disease in children. We found that experimental intrauterine growth restriction (IUGR) in sheep reduced cutaneous responses to antigens in progeny, despite normal or elevated IgE responses. Furthermore, maternal methyl donor supplementation in late pregnancy partially reversed effects of experimental IUGR, consistent with the proposal that epigenetic pathways underlie some but not all effects of IUGR on allergic susceptibility. Ovine experimental allergic asthma with exacerbations reduces relative fetal size in late gestation, with some changes in immune populations in fetal thymus suggestive of increased activation. Maternal allergic asthma in mice also predisposes progeny to allergy development. In conclusion, these findings in experimental models provide direct evidence that a perturbed environment before birth alters immune system development and postnatal function, and provide opportunities to investigate underlying mechanisms and develop and evaluate interventions.


Subject(s)
Amino Acids/therapeutic use , Asthma/immunology , Diet , Fetal Growth Retardation/immunology , Hypersensitivity/immunology , Prenatal Exposure Delayed Effects/immunology , Vitamins/therapeutic use , Animals , Asthma/diet therapy , Cattle , Female , Fetal Growth Retardation/diet therapy , Humans , Hypersensitivity/diet therapy , Maternal Exposure/adverse effects , Models, Animal , Pregnancy , Prenatal Exposure Delayed Effects/diet therapy , Sheep
8.
Placenta ; 54: 17-23, 2017 06.
Article in English | MEDLINE | ID: mdl-28131319

ABSTRACT

Asthma is a highly prevalent chronic medical condition affecting an estimated 12% of pregnant, women each year, with prevalence of asthma greatest (up to 16%) among the socially disadvantaged. Maternal asthma is associated with significant perinatal morbidity and mortality including preterm births, neonatal hospitalisations and low birthweight outcomes each year. We have identified that the placenta adapts to the presence of chronic, maternal asthma during pregnancy in a sex specific manner that may confer sex differences in fetal outcome. The male fetus was at greater risk of a poor outcome than a female fetus in the presence of maternal asthma and an acute inflammatory event such as an asthma exacerbation. This review will examine the role of sex specific differences in placental function on fetal growth and survival.


Subject(s)
Adaptation, Physiological , Asthma/physiopathology , Placenta/physiopathology , Pregnancy Complications/physiopathology , Androgens/physiology , Asthma/immunology , Female , Fetal Development , Glucocorticoids/metabolism , Humans , Hydrocortisone/physiology , Neovascularization, Pathologic , Oxidative Stress , Placenta/immunology , Placenta/metabolism , Pregnancy , Pregnancy Complications/immunology , Sex Characteristics , Somatomedins/metabolism
9.
Placenta ; 54: 24-29, 2017 06.
Article in English | MEDLINE | ID: mdl-28017357

ABSTRACT

The physiological mechanisms that confer different outcomes in morbidity and mortality of the fetus exposed to stressful environments may be driven by significant differences in the expression and function of the placental glucocorticoid receptor (GR). The recent discovery that the placenta contains at least 8 different isoforms of the GR raises questions about the regulation and physiological relevance of the many GR variants expressed in the placenta. The current data also highlights that individual differences in glucocorticoid sensitivity, variations in the effect of different complications of pregnancy on birth outcomes and sex differences in the response to stress, may all be dependent on a specific GR isoform expression profile. This review will investigate the current state of knowledge of GR isoforms in the placenta and discuss the potential role of these multiple isoforms in regulating glucocorticoid sensitivity.


Subject(s)
Adaptation, Physiological , Fetal Development , Placenta/metabolism , Pregnancy Complications/metabolism , Receptors, Glucocorticoid/metabolism , Animals , Epigenesis, Genetic , Female , Humans , Pregnancy , Protein Isoforms/metabolism
10.
BJOG ; 123(11): 1830-8, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27550725

ABSTRACT

OBJECTIVE: To estimate creatine concentrations in maternal plasma and urine, and establish relationships with maternal characteristics, diet and fetal growth. DESIGN: Retrospective cohort study. SETTING: Lyell McEwin Hospital, Adelaide, Australia. POPULATION: A biobank of plasma and urine samples collected at 13, 18, 30 and 36 weeks' gestation from 287 pregnant women from a prospective cohort of asthmatic and non-asthmatic women. METHODS: Creatine was measured by enzymatic analysis. Change in creatine over pregnancy was assessed using the Friedman test. Linear mixed models regression was used to determine associations between maternal factors and diet with creatine across pregnancy and between creatine with indices of fetal growth at birth. MAIN OUTCOME MEASURES: Maternal creatine concentrations, associations between maternal factors and creatine and between creatine and fetal growth parameters. RESULTS: Maternal smoking, body mass index, asthma and socio-economic status were positively and parity negatively associated with maternal plasma and/or urine creatine. Maternal urine creatine concentration was positively associated with birthweight centile and birth length. After adjustment, each µmol/l increase in maternal urinary creatine was associated with a 1.23 (95% CI 0.44-2.02) unit increase in birthweight centile and a 0.11-cm (95% CI 0.03-0.2) increase in birth length. CONCLUSIONS: Maternal factors and fetal growth measures are associated with maternal plasma and urine creatine concentrations. TWEETABLE ABSTRACT: Maternal creatine is altered by pregnancy; fetal growth measures are associated with maternal creatine concentrations.


Subject(s)
Creatine/blood , Creatine/urine , Fetal Development/physiology , Pregnancy Trimesters/blood , Pregnancy Trimesters/urine , Adult , Asthma/blood , Asthma/urine , Biological Specimen Banks , Birth Weight/physiology , Female , Gestational Age , Humans , Infant, Newborn , Linear Models , Parity , Pregnancy , Pregnancy Complications/blood , Pregnancy Complications/urine , Prospective Studies , Retrospective Studies , Smoking/blood , Smoking/urine , Social Class
11.
BJOG ; 123(12): 1929-1936, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26374444

ABSTRACT

OBJECTIVE: To investigate the association between antidepressant use in late gestation and postpartum haemorrhage (PPH). DESIGN: Retrospective cohort study. SETTING: Tertiary teaching hospital in Adelaide, Australia. POPULATION: A total of 30 198 women delivering between 2002 and 2008. METHODS: Relative risks adjusted for maternal sociodemographics and comorbidities (aRRs) were calculated for PPH, comparing women with late-gestation exposure to antidepressants (n = 558), women with a psychiatric illness but no antidepressant use (n = 1292), and women with neither antenatal exposures (n = 28 348). Additional sensitivity analyses were undertaken, examining associations with severe PPH and postpartum anaemia. MAIN OUTCOME MEASURES: The primary outcome was PPH, defined as a recorded blood loss of ≥500 mL for vaginal deliveries and ≥1000 mL for caesarean sections. Secondary outcomes included severe PPH (≥1000 mL blood loss, irrespective of method of delivery), and the presence of postpartum anaemia (identified from hospital medical records). RESULTS: Compared with unexposed controls, women exposed to antidepressants had an increased risk of PPH (aRR 1.53; 95% confidence interval, 95% CI 1.25-1.86), whereas no increased risk was observed for women with a psychiatric illness but no antidepressant use (aRR 1.04; 95% CI 0.89-1.23). In sensitivity analyses, late gestation antidepressant exposure was associated with an increased risk of severe PPH (aRR 1.84; 95% CI 1.39-2.44), as well as postpartum anaemia (aRR 1.80; 95% CI 1.46-2.22). CONCLUSIONS: Exposure to antidepressants in late gestation was associated with a significantly increased risk of PPH. Although potential confounding by unmeasured factors cannot be ruled out, these findings suggest a direct effect of antidepressant exposure on PPH. TWEETABLE ABSTRACT: Late gestation antidepressant exposure is associated with a significantly increased risk of postpartum haemorrhage.


Subject(s)
Postpartum Hemorrhage , Pregnancy Complications , Antidepressive Agents , Cesarean Section , Female , Humans , Retrospective Studies , Risk Factors
12.
Eur J Obstet Gynecol Reprod Biol ; 197: 48-53, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26706835

ABSTRACT

OBJECTIVE: We sought to investigate the impact of introducing an antenatal asthma management service (AMS) on asthma control during pregnancy and subsequent perinatal outcomes. STUDY DESIGN: Prospective, observational cohort study of pregnant asthmatic women attending a tertiary hospital antenatal clinic. Asthmatic women were recruited from the antenatal clinic and were followed prospectively with visits at 12, 20, 28 and 36 weeks gestation. A new nurse-led AMS was introduced offering asthma self-management education and support. Outcomes were compared between women recruited before and after the AMS was introduced (n=89 and 80, respectively) and included; prevalence of exacerbations during pregnancy, asthma control throughout pregnancy and perinatal outcomes, including preterm birth and small-for-gestational-age (SGA). RESULTS: The relative risk for exacerbations (0.69; CI: 0.33-1.42), loss of control (0.67; CI 0.46-0.99) and persistent uncontrolled asthma (0.48; CI 0.26-0.9) were all reduced with attendance to AMS during pregnancy. AMS was associated with non-statistically significant reductions in asthma exacerbations (19.1-15.0%; p=0.480) and uncontrolled asthma at ≥ 2 study visits (21.3-11.3%; p=0.078). CONCLUSIONS: These findings demonstrate the potential impact of an AMS in improving asthma control during pregnancy, supporting the need for an adequately powered RCT to determine its clinical- and cost-effectiveness.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Practice Patterns, Nurses' , Pregnancy Complications/drug therapy , Self Care , Administration, Inhalation , Adult , Asthma/physiopathology , Cohort Studies , Disease Management , Disease Progression , Female , Forced Expiratory Volume , Humans , Infant, Newborn , Infant, Small for Gestational Age , Male , Outpatient Clinics, Hospital , Pilot Projects , Pregnancy , Pregnancy Complications/physiopathology , Premature Birth/epidemiology , Prospective Studies , Smoking/therapy , Smoking Cessation , Tertiary Care Centers , Vital Capacity , Young Adult
13.
Aust Nurs Midwifery J ; 24(1): 37, 2016 07.
Article in English | MEDLINE | ID: mdl-29237118

ABSTRACT

Anal incontinence (AI) is the accidental loss of liquid or solid stool and flatus (Milsom et al. 2009). The concept of uncontrolled faecal loss can evoke social disgust and marginalize those afflicted from the community in which they live (Williams et al. 2005).


Subject(s)
Fecal Incontinence/etiology , Fecal Incontinence/nursing , Fecal Incontinence/physiopathology , Nurse's Role , Adult , Age Factors , Anal Canal/physiopathology , Delivery, Obstetric/adverse effects , Female , Humans , Quality of Life , Social Isolation
14.
J Dev Orig Health Dis ; 6(6): 485-92, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26434993

ABSTRACT

The objective was to investigate the association between early and late maternal smoking during pregnancy on offspring body mass index (BMI). We undertook a retrospective cohort study using linked records from the Women's and Children's Health Network in South Australia. Among a cohort of women delivering a singleton, live-born infants between January 2000 and December 2005 (n=7658), 5961 reported not smoking during pregnancy, 297 reported quitting smoking during the first trimester of pregnancy, and 1400 reported continued smoking throughout pregnancy. Trained nurses measured the height and weight of the children at preschool visits in a state-wide surveillance programme. The main outcome measure was age- and sex-specific BMI z-score. At 4 to 5 years, mean (s.d.) BMI z-score was 0.40 (1.05), 0.60 (1.07) and 0.65 (1.18) in children of mothers who reported never smoking, quitting smoking and continued smoking during pregnancy, respectively. Compared with the group of non-smokers, both quitting smoking and continued smoking were associated with an increase in child BMI z-score of 0.15 (95% confidence interval: 0.01-0.29) and 0.21 (0.13-0.29), respectively. A significant dose-response relationship was also observed between the number of cigarettes smoked per day on average during the second half of pregnancy and the increase in offspring BMI z-score (P<0.001). In conclusion, any maternal smoking in pregnancy, even if mothers quit, is associated with an increase in offspring BMI at 4 to 5 years of age.


Subject(s)
Prenatal Exposure Delayed Effects/epidemiology , Smoking/adverse effects , Body Mass Index , Child, Preschool , Female , Humans , Male , Pregnancy , Retrospective Studies , South Australia/epidemiology
15.
Placenta ; 36(7): 723-30, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25990415

ABSTRACT

INTRODUCTION: Administration of betamethasone to women at risk of preterm delivery is known to be associated with reduced fetal growth via alterations in placental function and possibly direct effects on the fetus. The placental glucocorticoid receptor (GR) is central to this response and recent evidence suggests there are numerous isoforms for GR in term placentae. In this study we have questioned whether GR isoform expression varies in preterm placentae in relation to betamethasone exposure, fetal sex and birthweight. METHODS: Preterm (24-36 completed weeks of gestation, n = 55) and term placentae (>37 completed weeks of gestation, n = 56) were collected at delivery. Placental GR expression was examined using Western Blot and analysed in relation to gestational age at delivery, fetal sex, birthweight and betamethasone exposure. Data was analysed using non-parametric tests. RESULTS: Eight known isoforms of the GR were detected in the preterm placenta and include GRα (94 kDa), GRß (91 kDa), GRα C (81 kDa) GR P (74 kDa) GR A (65 kDa), GRα D1-3 (50-55 kDa). Expression varied between preterm and term placentae with a greater expression of GRα C in preterm placentae relative to term placentae. The only sex differences in preterm placentae was that GRα D2 expression was higher in males than females. There were no alterations in preterm placental GR expression in association with betamethasone exposure. DISCUSSION: GRα C is the isoform involved in glucocorticoid induced apoptosis and suggests that its predominance in preterm placentae may contribute to the pathophysiology of preterm birth.


Subject(s)
Birth Weight , Gestational Age , Placenta/chemistry , Premature Birth/metabolism , Receptors, Glucocorticoid/analysis , Sex Characteristics , Betamethasone/pharmacology , Female , Fetal Development/drug effects , Glucocorticoids/pharmacology , Humans , Male , Placenta/drug effects , Pregnancy , Protein Isoforms/analysis , Term Birth/metabolism
16.
Midwifery ; 31(1): 74-9, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25017172

ABSTRACT

OBJECTIVE: to examine the informal approaches taken by midwives and other antenatal staff to adapt health communication to the needs of their patients, as well as their perception of the barriers faced when trying to provide tailored health promotion. DESIGN: qualitative research methods (participant observation, individual and group interviews) were utilised to gain an understanding of how media and communication resources were used in practice within the study hospital. SETTING: a major metropolitan teaching hospital located in the Northern suburbs of Adelaide, South Australia. PARTICIPANTS: individual semi-structured interviews with antenatal staff (n=8) were combined with group interviews (n=2; total number of staff=13), and observational research. FINDINGS: midwives and other antenatal staff use a range of strategies to meet the perceived health literacy level of their patients. However, their attempts to tailor health information to individual needs are frequently based on incomplete information about patients' health literacy, may be inconsistent in delivery and content and are seldom assessed to determine whether communication has been understood or led to patient behaviour change. KEY CONCLUSIONS: midwives fully recognise the need to adapt standard printed materials to meet the diverse health literacy needs of patients but lack the resources required to evaluate whether these adaptations have positive effect. IMPLICATIONS FOR PRACTICE: midwives' commitment to improving health communication provides a latent resource that institutions can build on to improve health outcomes for patients with low health literacy. This requires improvements in health communication training, willingness to use a range of validated instruments for measuring health literacy, and commitment to use of innovative approaches to health promotion where these have been shown to have a positive impact on health behaviours.


Subject(s)
Attitude of Health Personnel , Health Education/methods , Midwifery/methods , Nurse-Patient Relations , Parents/education , Female , Humans , Maternal Health Services/standards , Parents/psychology , Pregnancy
17.
Women Birth ; 27(3): 168-73, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25070730

ABSTRACT

BACKGROUND: Usage rates for information and communication technologies (ICTs) in healthcare have been increasing in recent years, but often lag behind general usage rates for populations as a whole. Research into such differential rates of ICT use across different segments of the population has identified a number of possible causal factors that limit usage. AIM: The research investigated midwives' attitudes and experiences of ICT use to identify potential causal factors that encourage or inhibit their usage in antenatal care. METHODS: Semi-structured interviews, focus groups and short surveys were conducted with midwives who provide antenatal education at an Australian metropolitan hospital. Thematic and statistical analyses were used to interpret the data. FINDINGS: Although midwives recognised the potential benefits of using ICTs to deliver pregnancy-related health information many had reservations about their use in everyday work. These reservations centred on lack of training in use of ICTs, the perceived legal risks associated with social media, potential violations of patient privacy, misdiagnosis and misunderstandings between midwife and client. CONCLUSION: Midwives face a number of barriers to effective use of ICTs in healthcare including material access, skills access, usage access and motivational access. Motivational access appears to be a key concern due to the high perception of risk associated with social media in particular. Reducing the motivational barriers through a range of interventions with midwifery staff may assist in overcoming other barriers to ICT use in antenatal care. Further research is required to determine whether these findings are generalisable to other healthcare contexts.


Subject(s)
Attitude of Health Personnel , Fear , Health Communication/methods , Nurse Midwives/psychology , Patient Education as Topic/methods , Prenatal Care/methods , Social Media/statistics & numerical data , Adult , Australia , Female , Focus Groups , Health Promotion , Humans , Interviews as Topic , Male , Middle Aged , Motivation , Nurse-Patient Relations , Pregnancy , Qualitative Research
19.
Placenta ; 35(4): 260-8, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24559727

ABSTRACT

INTRODUCTION: We have previously identified sex-specific differences in the fetal-placental response to cortisol. Our recent studies suggest that this differential response to cortisol is driven by differences in glucocorticoid receptor (GR) protein function rather than through changes in gene transcription or protein expression. METHODS: This study was designed to define whether the human placenta expresses different isoforms of the GR and whether expression was altered by fetal sex and maternal asthma. Asthma and non-asthma pregnant women were prospectively recruited at their first antenatal visit and placentae collected at delivery. Placental GR expression was examined in relation to maternal asthma, fetal sex and birthweight. RESULTS: Twelve specific bands for the GR were identified at molecular weights of 94, 91, 81, 74, 69, 68, 65, 60, 55, 50, 48 and 38 kDa. The 12 isoforms were localised to the placental trophoblast and expression varied in relation to cellular location in either the cytoplasm or nucleus, fetal sex, fetal size and the presence and absence of maternal asthma. CONCLUSION: This is the first study to identify the presence of several protein isoforms of the GR in the human placenta. The data suggest glucocorticoid resistance observed in male placentae may be mediated through increased GRß, GR A and GR P localisation to the nucleus. While female placentae may be more sensitive to cortisol in the presence of maternal asthma through a decrease in GRß and an enhancement GRα activity via an interaction with GRα D3 and GRα C.


Subject(s)
Asthma/metabolism , Placenta/metabolism , Pregnancy Complications/metabolism , Receptors, Glucocorticoid/metabolism , Sex Characteristics , Adrenal Cortex Hormones/therapeutic use , Adult , Asthma/drug therapy , Case-Control Studies , Female , Fetal Growth Retardation/metabolism , HEK293 Cells , Humans , Hydrocortisone/blood , Infant, Newborn , Male , Phosphorylation , Pregnancy , Pregnancy Complications/drug therapy , Protein Isoforms/metabolism
20.
Placenta ; 35 Suppl: S4-9, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24321782

ABSTRACT

Workshops are an important part of the IFPA annual meeting as they allow for discussion of specialized topics. At IFPA meeting 2013 there were twelve themed workshops, four of which are summarized in this report. These workshops related to various aspects of placental biology but collectively covered areas of pregnancy pathologies and placental metabolism: 1) diabetes in pregnancy; 2) lipids, fatty acids and the placenta; 3) oxygen in placental development and pathologies; 4) stem cells and pathologies.


Subject(s)
Diabetes, Gestational/metabolism , Dyslipidemias/physiopathology , Oxygen/physiology , Placentation , Animals , Female , Fetal Development , Humans , Pregnancy , Signal Transduction , Stem Cells/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...